Org.nr 915 108 598 2024 → 2025 Year-over-year analysis

ABLY MEDICAL AS: årsregnskap 2025 vs 2024

Shrank 78% on revenue, weaker earnings

approved 2026-06-26; registry 2026-07-21; journal 2026 605967

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2025 with 2024 for ABLY MEDICAL AS. Revenue 18.34m NOK → 3.97m NOK (-78.4%). Net result -3.08m NOK → -21.79m NOK. Equity 87.92m NOK → 67.13m NOK.

On the constructive side: cash rose. Pressures included: revenue fell; operating result weakened; net result weakened.

Also worth watching: paid-in equity reduced; headcount (årsverk) changed. All figures are taken from the published annual accounts for ABLY MEDICAL AS.

Scorecard

Revenue
18.34m NOK 3.97m NOK
-78.4%
Operating result
-3.11m NOK -18.22m NOK
-486.0%
Net result
-3.08m NOK -21.79m NOK
-607.5%
Equity
87.92m NOK 67.13m NOK
-23.6%
Cash
474.6k NOK 6.20m NOK
+1206.8%
Total assets
99.93m NOK 108.58m NOK
+8.7%

What improved

  • ↑

    Cash rose

    Bank deposits 474.6k NOK → 6.20m NOK (+1206.8% YoY). Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 18.34m NOK to 3.97m NOK (-78.4% YoY). Calculated

  • ↓

    Operating result weakened

    Operating result -3.11m NOK → -18.22m NOK (op. margin -17.0% → -459.2%). Calculated

  • ↓

    Net result weakened

    Net result -3.08m NOK → -21.79m NOK (net margin -16.8% → -549.0%). Calculated

  • ↓

    Equity eroded

    Book equity 87.92m NOK → 67.13m NOK (equity ratio 88.0% → 61.8%). Calculated

  • ↓

    Payroll up without matching revenue

    Salary cost 4.43m NOK → 5.78m NOK (24% → 146% of revenue). Calculated

Things to notice

  • ·

    Paid-in equity reduced

    Paid-in equity fell 99.52m NOK → 78.73m NOK — check capital reduction, conversion, or reclassification. Interpretation

  • ·

    Headcount (årsverk) changed

    Reported FTEs 8.86 → 10.22. Reported fact